Movement Disorders and Neurodegenerative Diseases
A section of Neurology International (ISSN 2035-8377).
Section Information
Movement disorders and neurodegenerative diseases encompass a range of conditions that affect the nervous system and lead to abnormal motor function. Movement disorders refer to a group of diseases that cause abnormal or excessive movements, including Parkinson's disease, essential tremor, and dystonia. Neurodegenerative diseases involve the gradual loss of neurons’ structure or function. In addition to motor symptoms, they often present with cognitive and psychiatric impairments. For instance, Alzheimer's disease, although not a typical movement disorder, can also lead to motor dysfunction in its later stages. It is primarily characterized by progressive cognitive impairment and behavioral deterioration. Huntington's disease is another neurodegenerative disorder that causes involuntary movements, cognitive deficits, and psychiatric symptoms. The etiology of these diseases is complex, involving genetic, environmental, and neurodegenerative factors that significantly impact the quality of life of patients and pose a substantial burden on healthcare systems and society. The Section on “Movement Disorders and Neurodegenerative Diseases” will explore research in the diagnosis, pathogenesis, treatment, and clinical management of these conditions.
Keywords
- Parkinson's disease
- Movement disorders
- Neurodegenerative diseases
- Essential tremor
- Dystonia
- Alzheimer's disease
- Huntington's disease
- Neurodegeneration
- Dopaminergic neurons
- Amyloid plaques
- Abnormal protein
- Mitochondrial dysfunction
Editorial Board
Click here to see the Section Editorial Board of "Movement Disorders and Neurodegenerative Diseases".
Special Issues
Following special issues within this section are currently open for submissions:
- New Insights into Movement Disorders (Deadline: 31 July 2025)
- Advances in Novel Treatment and Rehabilitation for Strokes (Deadline: 31 July 2025)
- Innovations in Acute Stroke Treatment, Neuroprotection, and Recovery (Deadline: 30 October 2025)
- Biomarker Research in Neuromuscular Diseases (Deadline: 30 November 2025)
- Towards an All-Inclusive Paradigm for Acute Stroke Treatment—Challenges and Innovations (Deadline: 30 November 2025)
- Advances in Molecular Mechanisms of Neurodegenerative Diseases (Deadline: 30 November 2025)
- Pathogenesis and Therapeutic Intervention of Alzheimer's Disease (Deadline: 31 December 2025)
- Mitochondria in Neurodegenerative Disease: Mechanisms and Therapeutic Targets (Deadline: 31 December 2025)
- Novel Early Biomarker Identification and Treatment Strategy for Alzheimer's Disease (Deadline: 31 December 2025)
- Molecular and Cellular Research of Neuroprotection and Neurodegeneration (Deadline: 30 January 2026)
- Neurotrophic Factors: A Focus on the Therapeutic Level (Deadline: 30 January 2026)
- Molecular Research of CNS Diseases and Neurological Disorders (Deadline: 28 February 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
